Cynthia Comella, MD

Cynthia L. Comella, MD, is Professor Emeritus in the Department of Neurological Sciences at Rush University Medical Center, Chicago, Illinois. She is board certified in Neurology and Sleep Medicine.

Dr. Comella is the Immediate Past President of the International Neurotoxin Association. She is an active member of the International Parkinson and Movement Disorders Society (MDS), having served as Chair of the Education Committee and Executive Committee, and Secretary, and currently Chair of the MDS-Pan American Section. She received the MDS President’s Distinguished Service Award in 2008 and was the Stanley Fahn Presidential Lecturer in 2019. She directs the young leadership program in the MDS (LEAP program) and serves on the PAS Congress Scientific Planning Committee.

Dr. Comella is also a member of the American Academy of Neurology (AAN) and has chaired the AAN Education Committee, served on the Science Committee, and currently serves on the Leadership Development Committee. She is the program director for the AAN Women Leading in Neurology (WLN) program that educates mid-career women in the skills of leadership and negotiation. She has served on the editorial board of Continuum, an AAN publication, completed the AAN Palatucci Advocacy Fellowship, and has participated in Neurology on the Hill, an advocacy experience sponsored by the AAN.

Dr. Comella is on the editorial board of Sleep Medicine and Clinical Neuropharmacology and has served as an ad hoc reviewer for several peer-reviewed journals. She is actively involved in many educational activities, including serving as faculty, MDS ambassador, and on numerous grand rounds. She continues her research in dystonia, funded by the Department of Defense, and is on the Executive Committee of the Dystonia Coalition.

Dr. Comella is the author or co-author of more than 180 articles, reviews, research papers, abstracts, books, and book chapters about various topics, including Parkinson’s disease, dystonia, sleep and sleep-related disorders, restless legs syndrome, and botulinum toxin.

Join Our Mailing List

Click here to sign up, and then manage your subscription.